Six-month outcomes from the Ventricular Catheter Ablation Study, the first-in-human evaluation of its FieldForce Ablation ...
An Abbott (NYSE: ABT) official posted on social media to announce FDA breakthrough device designation for a new ablation ...
MedPage Today on MSN
RT Matches Catheter Ablation for Refractory Ventricular Tachycardia, and It's Safer
S AN FRANCISCO -- Noninvasive stereotactic radiotherapy (RT) for refractory ventricular tachycardia (VT) achieved outcomes ...
Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, and CardioFocus, Inc., a medical device company dedicated to advancing ...
Patients with refractory VT may be too medically fragile to safely undergo a repeat catheter ablation. Is stereotactic ...
Aqua Medical is targeting the duodenum with radiofrequency vapor ablation (RFVA) to treat patients with type 2 diabetes.
Radiation therapy may offer a comparable and potentially safer alternative to repeat catheter ablation for patients with severe abnormal heart rhythms that can no longer be controlled with medication.
Radiation therapy may offer a comparable and potentially safer alternative to repeat catheter ablation for patients with severe abnormal heart rhythms that can no longer be controlled with medication.
SAN FRANCISCO, September 29, 2025 — Radiation therapy may offer a comparable and potentially safer alternative to repeat catheter ablation for patients with severe abnormal heart rhythms that can no ...
Background: Unlike the tremendous progress made in atrial fibrillation ablation, the greatest unmet clinical need is for innovative ablation treatments for scar-related ventricular tachycardia (VT) – ...
Radiation therapy may offer a comparable and potentially safer alternative to repeat catheter ablation for patients with severe abnormal heart rhythms that can no longer be controlled with medication.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback